More than three years after the U.S. Food & Drug Administration (FDA) issued an Actos bladder cancer warning, our Firm continues to hear from individuals who may have developed the disease due to long-term use of this drug.
New York, New York (PRWEB) November 10, 2013
Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) filed on behalf of patients who developed bladder cancer, allegedly due to long-term use of the Type 2 diabetes drug continue to move forward in a multidistrict litigation underway in U.S. District Court, Western District of Louisiana. According to court documents, the next Status Conference in the federal Actos bladder cancer litigation has been scheduled for November 21, 2013. (In re: Actos Product Liability Litigation, MDL No. 2299)
“More than three years after the U.S. Food & Drug Administration (FDA) issued an Actos bladder cancer warning, our Firm continues to hear from individuals who may have developed the disease due to long-term use of this drug. We are pleased with the progress of this proceeding thus far,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos lawsuit evaluations to individuals who were diagnosed with bladder cancer following long-term use of the drug.
Actos and Bladder Cancer
In June 2011, the FDA warned that use of Actos for more than a year had been linked to a doubling of the risk of developing bladder cancer. Since then, more than 2,580 Actos lawsuits involving bladder cancer allegations have been filed in the Western District of Louisiana. All of the claims allege that Takeda Pharmaceuticals and other defendants concealed knowledge that Actos could increase a person’s chances of developing bladder cancer, and failed to provide adequate warnings about that risk to the public and medical community. The first Actos bladder lawsuit trials will begin in the federal litigation in January 2014.
According to court documents, at least two lawsuits over Actos bladder cancer claims have already gone to trial. Just this past September, the second Actos lawsuit trial concluded in Maryland State Court with $1.7 million being awarded to the family of a man who died of bladder cancer. However, according to court records, the judge presiding over the trial set aside the verdict in accordance with Maryland law because the jury also found that the decedent’s decades-long smoking habit contributed to the development of the disease. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland.)
The nation’s first trial of an Actos lawsuit concluded in April in Los Angeles Superior Court. At that time, the jury awarded $6.5 million to a plaintiff who was diagnosed with bladder cancer after taking Actos for four years. However, the plaintiff recently appealed a decision by the judge overseeing the case to grant Takeda Pharmaceuticals’ request to set aside the verdict. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)
Alleged victims of Actos and bladder cancer may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn More about filing an Actos bladder cancer lawsuit by visiting Bernstein Liebhard LLP’s website. For additional information, please call 800-511-5092 today.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP